13 valent Pneumococcal Polysaccharide Conjugate Vaccine (Sinovac)
13价肺炎球菌多糖结合疫苗（科兴）
Report date: 2026/05/12 20:00:17
Base Information
Drug Name13 valent Pneumococcal Polysaccharide Conjugate Vaccine (Sinovac)
Drug Alias NameN/A
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
Originator CompaniesSinovac Research And Development Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A